TSC1 and neoplasm: This is to say, drugs inhibiting a negative interactor would presumably suppress only the growth of tumor cells (which bear two mutant copies of the affected TSC gene: the inherited mutant germline copy, and the copy affected by the ‘second-hit’) while leaving phenotypically normal cells (carrying only the mutant germline copy) unaffected.